Selective estrogen-receptor modulators for primary prevention of breast cancer

J Clin Oncol. 2005 Mar 10;23(8):1644-55. doi: 10.1200/JCO.2005.11.005.
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Breast Neoplasms / prevention & control*
  • Female
  • Humans
  • Postmenopause
  • Premenopause
  • Primary Prevention / methods*
  • Raloxifene Hydrochloride* / adverse effects
  • Raloxifene Hydrochloride* / therapeutic use
  • Randomized Controlled Trials as Topic
  • Receptors, Estrogen* / classification
  • Receptors, Estrogen* / drug effects
  • Receptors, Estrogen* / physiology
  • Selective Estrogen Receptor Modulators* / adverse effects
  • Selective Estrogen Receptor Modulators* / pharmacology
  • Selective Estrogen Receptor Modulators* / therapeutic use
  • Tamoxifen* / adverse effects
  • Tamoxifen* / therapeutic use

Substances

  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Tamoxifen
  • Raloxifene Hydrochloride